Pembrolizumab in hemodialysis patients. Is it safe?

Nefrologia (Engl Ed). 2020 Nov-Dec;40(6):678-679. doi: 10.1016/j.nefro.2019.11.007. Epub 2020 Apr 27.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma, Clear Cell / drug therapy*
  • Adenocarcinoma, Clear Cell / secondary
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • B7-H1 Antigen / metabolism
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Glomerulonephritis, IGA / therapy
  • Graft Rejection / immunology
  • Humans
  • Kidney Transplantation
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Peritoneal Dialysis
  • Reoperation
  • Ribs*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • B7-H1 Antigen
  • CD274 protein, human
  • pembrolizumab